Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed security
Listed on NASDAQ
IE headquartered
Headquartered in Dublin, Leinster, Ireland

Amarin Corporation plc

$7.55
AMRN
Jan 25, 3:42:20 PM GMT-5 · USD · NASDAQ · Disclaimer

In the news

Financial performance
(USD)Q3 2020Year/year change
Revenue
156.50M39.22%
Net income
-6.79M-96.07%
Diluted EPS-0.02-100.00%
Net profit margin-4.34%-40.91%
Operating income-6.94M-53.61%
Net change in cash-6.80M-101.50%
Cash on hand207.21M-69.22%
Cost of revenue33.07M29.98%
About
Amarin Corporation is a biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Founded
1993
Employees
965

Key stats

Previous close
The last closing price
$6.55
Day range
The difference between the high and low prices over the past day
$6.96 - $7.64
Year range
The difference between the high and low prices over the past 52 weeks
$3.36 - $20.80
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
2.95B USD
Volume
The average number of shares traded each day over the past 30 days
8.02M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
-
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
About
Amarin Corporation is a biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Founded
1993
Employees
965

Discover more

You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

People also search for

Search
Clear search
Close search
Google apps
Main menu